Company profile
Neuvasq Biotechnologies
Advancing innovative Wnt surrogate antibodies to restore blood-CNS barriers.
- Industry
- Biotechnology
- Employees
- 15
- Headquarters
- Gosselies
- Founded
- 2021
- Office locations
- 1
Neuvasq Biotechnologies company summary
Neuvasq Biotechnologies is a company in the Biotechnology industry, headquartered in Gosselies, founded in 2021. On LinkedIn the company has around 15 employees.
What technology does Neuvasq Biotechnologies use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Neuvasq Biotechnologies
Neuvasq Biotechnologies is pioneering the development of first-in-class Gpr124- and Reck-targeting Wnt surrogate antibodies, designed to restore the integrity of the blood-retina and blood-brain barriers. This groundbreaking approach holds the potential to transform treatments and improve the lives of patients with vascular retinopathies – diabetic macular edema (DME) and wet age-related macular degeneration (wAMD) – or severe neurological disorders.
Where is Neuvasq Biotechnologies located?
Neuvasq Biotechnologies lists 1 location.
Compare companies similar to Neuvasq Biotechnologies
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Neuvasq Biotechnologies neuvasq.com | Biotechnology | 15 | 2021 | Gosselies |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Neuvasq Biotechnologies
What does Neuvasq Biotechnologies do?
Neuvasq Biotechnologies is pioneering the development of first-in-class Gpr124- and Reck-targeting Wnt surrogate antibodies, designed to restore the integrity of the blood-retina and blood-brain barriers. This groundbreaking approach holds the potential to transform treatments and improve the lives of patients with vascular retinopathies – diabetic macular edema (DME) and wet age-related macular degeneration (wAMD) – or severe neurological disorders.
How many employees does Neuvasq Biotechnologies have?
Neuvasq Biotechnologies has around 15 employees on LinkedIn.
Where is Neuvasq Biotechnologies headquartered?
Neuvasq Biotechnologies is headquartered in Gosselies.
When was Neuvasq Biotechnologies founded?
Neuvasq Biotechnologies was founded in 2021.
Build a lead list from companies like Neuvasq Biotechnologies
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.